Vericel Corp financial data

Symbol
VCEL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
64 Sidney St., Cambridge, Massachusetts
State of incorporation
Michigan
Fiscal year end
December 31
Former names
AASTROM BIOSCIENCES INC (to 11/14/2014)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 497 % -14.3%
Quick Ratio 34.6 % -36.2%
Debt-to-equity 55.2 % +39.5%
Return On Equity 0.21 %
Return On Assets 0.13 %
Operating Margin -1.81 % +82.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.6M shares +2.18%
Common Stock, Shares, Outstanding 48.5M shares +2.07%
Entity Public Float 1.77B USD +50.6%
Common Stock, Value, Issued 641M USD +6.49%
Weighted Average Number of Shares Outstanding, Basic 48.1M shares +1.59%
Weighted Average Number of Shares Outstanding, Diluted 48.1M shares +1.59%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 208M USD +22.7%
Revenue from Contract with Customer, Excluding Assessed Tax 208M USD +23%
Research and Development Expense 22.2M USD +9.62%
Operating Income (Loss) -3.75M USD +79.1%
Nonoperating Income (Expense) 5.02M USD +219%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.37M USD +85.2%
Income Tax Expense (Benefit) 814K USD +12.9%
Net Income (Loss) Attributable to Parent 451K USD +48.5%
Earnings Per Share, Basic 0.01 USD/shares +50%
Earnings Per Share, Diluted 0.01 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 62.9M USD +1.79%
Accounts Receivable, after Allowance for Credit Loss, Current 49.9M USD +30.2%
Inventory, Net 13.6M USD -11.8%
Other Assets, Current 7.78M USD +71.3%
Assets, Current 190M USD +6.86%
Operating Lease, Right-of-Use Asset 73.7M USD +80.4%
Other Assets, Noncurrent 717K USD -42.6%
Assets 357M USD +34.5%
Accounts Payable, Current 19.4M USD +74.7%
Employee-related Liabilities, Current 3.39M USD +23.9%
Accrued Liabilities, Current 11M USD -15.9%
Liabilities, Current 36.5M USD +26.8%
Operating Lease, Liability, Noncurrent 86.1M USD +103%
Other Liabilities, Noncurrent 154K USD
Liabilities 123M USD +72.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -245K USD +61.5%
Retained Earnings (Accumulated Deficit) -407M USD +0.11%
Stockholders' Equity Attributable to Parent 234M USD +20.6%
Liabilities and Equity 357M USD +34.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.2M USD -8.37%
Net Cash Provided by (Used in) Financing Activities 2.13M USD +1887%
Net Cash Provided by (Used in) Investing Activities -25.5M USD -1009%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 48.5M shares +2.07%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.1M USD -250%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.7M USD +14.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 383K USD +251%
Deferred Tax Assets, Valuation Allowance 49.8M USD +5.21%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 70.7M USD +17.5%
Operating Lease, Liability 85M USD
Depreciation 4.2M USD +2.44%
Payments to Acquire Property, Plant, and Equipment 14M USD +892%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 842K USD +44%
Lessee, Operating Lease, Liability, to be Paid 158M USD
Operating Lease, Liability, Current 6.01M USD +33.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.7M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 10.7M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +18.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 49.6M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 14M USD
Deferred Tax Assets, Operating Loss Carryforwards 4.51M USD -35.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.4M USD
Depreciation, Depletion and Amortization 1.38M USD +19%
Interest Expense 608K USD +23.3%